Skip to main content
. Author manuscript; available in PMC: 2021 Aug 13.
Published in final edited form as: Nat Metab. 2020 Sep 28;2(10):1113–1125. doi: 10.1038/s42255-020-00279-2

Table 1 |.

MR demonstrating a positive association between RIPK1 expression and obesity risk by using data from GWAS and eQTL sources

RIPK1 eQTL study (exposure) Obesity study (outcome) Tissue Beta (MR) s.e. (MR) P value (MR) Number of SNPs (MR)
METSIM OBLE19 Adipose (subcutaneous) 0.26941 0.13983 0.054018 3
GTEx18 Riveros-McKay et al.77 Adipose (visceral omentum) 0.666114 0.282809 0.0185633 3
GTEx18 OBLE19 Adipose (subcutaneous) 0.742815 0.242662 0.0022052 8
METSIM Riveros-McKay et al.77 Adipose (subcutaneous) 0.163246 0.065646 0.0128912 9
GTEx18 UK-Biobank (impedance of whole body) Adipose (subcutaneous) −0.00985636 0.00457773 0.0313101 23
GTEx18 UK-Biobank (impedance of whole body) Adipose (subcutaneous) −0.841754 0.398739 0.0347689 23
Lloyd-Jones et al.78 OBLE19 Blood 0.293619 0.133475 0.027821 29
Westra et al.23 Riveros-McKay et al.77 Blood 0.349417 0.14985 0.019712 6
Westra et al.23 OBLE19 Blood 1.41146 0.350033 5.522 × 10−5 5
Lloyd-Jones et al.78 UK Biobank (impedance of whole body) Blood −0.00624607 0.00313365 0.0462366 18
Lloyd-Jones et al.78 UK Biobank (impedance of whole body) Blood −0.551498 0.273545 0.0437882 18